Whole-body MRI for the detection of bone marrow involvement in lymphoma: Prospective study in 116 patients and comparison with FDG-PET

European Radiology

Volumn 23, Issue 8, 2013, Pages 2271-2278

  Adams, Hugo J A ^a   Kwee, Thomas C ^a   Vermoolen, Malou A ^a   De Keizer, Bart ^a   De Klerk, John M H ^b   Adam, Judit A ^c   Fijnheer, Rob ^b   Kersten, Marie José ^c   Stoker, Jaap ^c   Nievelstein, Rutger A J ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b MEANDER MEDICAL CENTER   (Netherlands)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Bone marrow; FDG PET; Hodgkin; Lymphoma; Whole body MRI

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADOLESCENT; ADULT; AGED; ANGIOIMMUNOBLASTIC T CELL LYMPHOMA; ARTICLE; B CELL LYMPHOMA; BONE MARROW BIOPSY; BONE MARROW DISEASE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DIFFUSION WEIGHTED IMAGING; FEMALE; FOLLICULAR LYMPHOMA; HODGKIN DISEASE; HUMAN; ILIAC CREST; LARGE CELL LYMPHOMA; LYMPHOCYTOMA; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MANTLE CELL LYMPHOMA; MARGINAL ZONE LYMPHOMA; MULTICENTER STUDY; NODAL MARGINAL ZONE LYMPHOMA; POSITRON EMISSION TOMOGRAPHY; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; WHOLE BODY MRI;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOPSY; BONE MARROW; BONE MARROW NEOPLASMS; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LYMPHOMA; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; WHOLE BODY IMAGING; YOUNG ADULT;

EID: 84880329906     PISSN: 09387994     EISSN: 14321084     Source Type: Journal    
DOI: 10.1007/s00330-013-2835-9     Document Type: Article

References (28)

1. Siegel R, Naishadham D, Jemal A (2012) Cancer statistics, 2012. CA Cancer J Clin 62:10-29
2. Connors JM (2005) State-of-the-art therapeutics: Hodgkin's lymphoma. J Clin Oncol 23:6400-6408
3. Shankland KR, Armitage JO, Hancock BW (2012) Non-Hodgkin lymphoma. Lancet 380:848-587
4. Lister TA, Crowther D, Sutcliffe SB et al (1989) Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting. J Clin Oncol 7:1630-1636
5. Armitage JO (2005) Staging non-Hodgkin lymphoma. CA Cancer J Clin 55:368-376
6. Bain BJ (2006) Morbidity associated with bone marrow aspiration and trephine biopsy - a review of UK data for 2004. Haematologica 91:1293-1294
7. Brunning RD, Bloomfield CD, McKenna RW, Peterson LA (1975) Bilateral trephine bone marrow biopsies in lymphoma and other neoplastic diseases. Ann Intern Med 82:365-366
8. Coller BS, Chabner BA, Gralnick HR (1977) Frequencies and patterns of bone marrow involvement in non-Hodgkin lymphomas: observations on the value of bilateral biopsies. Am J Hematol 3:105-119
9. Haddy TB, Parker RI, Magrath IT (1989) Bone marrow involvement in young patients with non-Hodgkin's lymphoma: the importance of multiple bone marrow samples for accurate staging. Med Pediatr Oncol 17:418-423
10. Wang J, Weiss LM, Chang KL et al (2002) Diagnostic utility of bilateral bone marrow examination: significance of morphologic and ancillary technique study in malignancy. Cancer 94:1522-1531
11. Bairey O, Shpilberg O (2007) Is bone marrow biopsy obligatory in all patients with non-Hodgkin's lymphoma? Acta Haematol 118:61-64
12. Vande Berg BC, Malghem J, Lecouvet FE, Maldague B (1998) Magnetic resonance imaging of normal bone marrow. Eur Radiol 8:1327-1334
13. Vande Berg BC, Lecouvet FE, Michaux L, Ferrant A, Maldague B, Malghem J (1998) Magnetic resonance imaging of the bone marrow in hematological malignancies. Eur Radiol 8:1335-1344
14. Brennan DD, Gleeson T, Coate LE, Cronin C, Carney D, Eustace SJ (2005) A comparison of whole-body MRI and CT for the staging of lymphoma. AJR Am J Roentgenol 185:711-716
15. Ribrag V, Vanel D, Leboulleux S et al (2008) Prospective study of bone marrow infiltration in aggressive lymphoma by three independent methods: whole-body MRI, PET/CT and bone marrow biopsy. Eur J Radiol 66:325-331
16. Kwee TC, Fijnheer R, Ludwig I et al (2010) Whole-body magnetic resonance imaging, including diffusion-weighted imaging, for diagnosing bone marrow involvement in malignant lymphoma. Br J Haematol 149:628-630
17. Delbeke D, Stroobants S, de Kerviler E, Gisselbrecht C, Meignan M, Conti PS (2009) Expert opinions on positron emission tomography and computed tomography imaging in lymphoma. Oncologist 14:30-40
18. Pakos EE, Fotopoulos AD, Ioannidis JP (2005) 18F-FDG PET for evaluation of bone marrow infiltration in staging of lymphoma: a meta-analysis. J Nucl Med 46:958-963
19. Chen YK, Yeh CL, Tsui CC, Liang JA, Chen JH, Kao CH (2011) F-18 FDG PET for evaluation of bone marrow involvement in non-Hodgkin lymphoma: a meta-analysis. Clin Nucl Med 36:553-559
20. Salaun PY, Gastinne T, Bodet-Milin C et al (2009) Analysis of 18F-FDG PET diffuse bone marrow uptake and splenic uptake in staging of Hodgkin's lymphoma: a reflection of disease infiltration or just inflammation? Eur J Nucl Med Mol Imaging 36:1813-1821
21. Basu S, Torigian D, Alavi A (2008) Evolving concept of imaging bone marrow metastasis in the twenty-first century: critical role of FDG-PET. Eur J Nucl Med Mol Imaging 35:465-471
22. Weiler-Sagie M, Bushelev O, Epelbaum R et al (2010) (18)F-FDG avidity in lymphoma readdressed: a study of 766 patients. J Nucl Med 51:25-30
23. Tsukamoto N, Kojima M, Hasegawa M et al (2007) The usefulness of (18)F-fluorodeoxyglucose positron emission tomography ((18)F-FDG-PET) and a comparison of (18)F-FDG-pet with (67)gallium scintigraphy in the evaluation of lymphoma: relation to histologic subtypes based on the World Health Organization classification. Cancer 110:652-659
24. Kwee TC, Ludwig I, Uiterwaal CS et al (2011) ADC measurements in the evaluation of lymph nodes in patients with non-Hodgkin lymphoma: feasibility study. MAGMA 24:1-8
25. Tsunoda S, Takagi S, Tanaka O, Miura Y (1997) Clinical and prognostic significance of femoral marrow magnetic resonance imaging in patients with malignant lymphoma. Blood 89:286-29
26. Moulin-Romsee G, Hindié E, Cuenca X et al (2010) (18)F-FDG PET/CT bone/bone marrow findings in Hodgkin's lymphoma may circumvent the use of bone marrow trephine biopsy at diagnosis staging. Eur J Nucl Med Mol Imaging 37:1095-1105
27. El-Galaly TC, d'Amore F, Mylam KJ et al (2012) Routine bone marrow biopsy has little or no therapeutic consequence for positron emission tomography/computed tomography-staged treatment-naive patients with Hodgkin lymphoma. J Clin Oncol 30:4508-4514
28. Kwee TC, Akkerman EM, Fijnheer R et al (2011) MRI for staging lymphoma: whole-body or less? J Magn Reson Imaging 33:1144-1150